Limb girdle muscular dystrophies
ICD-10 G71.03 is a billable code used to indicate a diagnosis of limb girdle muscular dystrophies.
Limb girdle muscular dystrophies (LGMD) are a group of inherited disorders characterized by progressive weakness and wasting of the proximal muscles, particularly those around the hips and shoulders. These conditions are caused by genetic mutations that affect muscle proteins, leading to muscle degeneration and weakness. LGMD can be classified into several subtypes, each associated with different genetic defects. Symptoms typically begin in childhood or early adulthood, but onset can vary widely. Patients may experience difficulty with activities such as climbing stairs, lifting objects, or raising their arms. Diagnosis is often confirmed through genetic testing, muscle biopsy, and electromyography. Management focuses on maintaining mobility and function, with physical therapy playing a crucial role. While there is currently no cure for LGMD, ongoing research aims to develop targeted therapies that address the underlying genetic causes of these disorders.
Detailed neurological examination findings, genetic testing results, and progression of symptoms.
Patients presenting with muscle weakness, difficulty in mobility, and family history of muscular dystrophy.
Ensure clear documentation of muscle strength testing and any referrals to genetic counseling.
Functional assessments, therapy progress notes, and patient-reported outcomes.
Patients requiring rehabilitation services to maintain mobility and function.
Document specific therapeutic interventions and their impact on patient function.
When a muscle biopsy is performed to confirm the diagnosis of LGMD.
Document the indication for the biopsy, findings, and results.
Ensure that the procedure is linked to the diagnosis of LGMD.
Limb girdle muscular dystrophies are primarily caused by genetic mutations affecting proteins necessary for muscle function, leading to muscle weakness and degeneration.
